Skip to main content
Have a personal or library account? Click to login
Prognostic Value of Epicardial Fat Thickness as a Biomarker of Increased Inflammatory. Status in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Cover

Prognostic Value of Epicardial Fat Thickness as a Biomarker of Increased Inflammatory. Status in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction

Journal of Cardiovascular Emergencies
Volume 2 (2016): Issue 1 (March 2016)
By: ,  ,  ,  ,   and    
Open Access
|Jun 2016
References

References

  1. 1. Zhang Y, Hu G, Yuan Z, Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2012;7:e42551. doi: 10.1371/journal.pone.0042551.
    Open DOISearch in Google Scholar
  2. 2. Goldenberg I. Inflammatory markers and the risk of recurrent coronary events: the importance of dynamic risk assessment. Cardiol J. 2007;14:11-13.
    Search in Google Scholar
  3. 3. Erzen B, Šabovic M, Poredoš P, Šebeštjen M, Keber I, Simcic LS. Inflammation markers in young post-myocardial patients exhibiting various expressions of classic coronary risk factors. Coronary Artery Disease. 2006;17:325-330.
    Open DOISearch in Google Scholar
  4. 4. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-1553. doi: 10.1161/01.RES.0000130526.20854.fa.
    Open DOISearch in Google Scholar
  5. 5. Biasucci LM, Liuzzo G, Della Bona R, et al. Different Apparent Prognostic Value of hsCRP in Type 2 Diabetic and Nondiabetic Patients with Acute Coronary Syndromes. Clin Chem. 2009;55:365-368. doi: 10.1373/clinchem.2008.119156.
    Open DOISearch in Google Scholar
  6. 6. Schulze M, Rimm E, Li T, Rifai N. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care. 2004;27:889-894. http://dx.doi.org/10.2337/diacare.27.4.889.
    Open DOISearch in Google Scholar
  7. 7. Peterson LR, McKenzie CR, Schaffer JE. Diabetic cardiovascular disease: getting to the heart of the matter. J Cardiovasc Transl Res. 2012;5:436-445. doi: 10.1007/s12265-012-9374-7.
    Open DOISearch in Google Scholar
  8. 8. Yorgun H, Canpolat U, Hazırolan T, et al. Increased epicardial fat tissue is a marker of metabolic syndrome in adult patients. Int J Cardiol. 2013;165:308-313. doi: 10.1016/j. ijcard.2011.08.067.
    Search in Google Scholar
  9. 9. Harada K, Amano T, Uetani T, et al. Cardiac 64-multislice computed tomography reveals increased epicardial fat volume in patients with acute coronary syndrome. Am J Cardiol. 2011;108:1119-1123. doi: 10.1016/j.amjcard.2011.06.012.
    Open DOISearch in Google Scholar
  10. 10. Yerramasu A, Dey D, Venuraju S, et al. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis. 2012;220:223-230. doi: 10.1016/j. atherosclerosis.2011.09.041.
    Search in Google Scholar
  11. 11. Sabatine MS, Morrow DA, Jablonski KA, et al; PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association highsensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circ. 2007;115:1528-1536. doi: 10.1161/ CIRCULATIONAHA.106.649939
    Open DOISearch in Google Scholar
  12. 12. Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T. Highsensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes. A 7-year followup study. Diabetes Care. 2006;29:329-333. http://dx.doi.org/10.2337/diacare.29.02.06.dc05-1700.
    Open DOISearch in Google Scholar
  13. 13. Karaca I, Aydin K, Yavuzkir M, Ilkay E, Akbulut M. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary stent implantation. J Int Med Res. 2005;33:389-396.
    Open DOISearch in Google Scholar
  14. 14. Wilson MW, Marno CR, Andrew JB. The novel role of C reactive protein in cardiovascular disease: risk marker or pathyogen. Int J Cardiol. 2006;106:291-297. doi: http://dx.doi.org/10.1016/j.ijcard.2005.01.068.
    Open DOISearch in Google Scholar
  15. 15. von Bibra H, St John Sutton M. Impact of diabetes on postinfarction heart failure and left ventricular remodeling. Curr Heart Fail Rep. 2011;8:242-251. doi: 10.1007/s11897-011-0070-8.
    Open DOISearch in Google Scholar
  16. 16. Swiatkiewicz I, Kozinski M, Magielski P, et al. Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction. Inflamm Res. 2013;61:725-734. doi: 10.1007/s00011-012-0466-2.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/jce-2016-0003 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Journal RSS Feed
Language: English
Page range: 11 - 18
Submitted on: Oct 15, 2015
Accepted on: Jan 20, 2016
Published on: Jun 3, 2016
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
inflammation,
remodeling,
ventricular function,
postmyocardial infarction
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology,
Emergency medicine and intensive-care medicine,
Radiology

© 2016 Diana Opincariu, András Mester, Mihaela Dobra, Nora Rat, Roxana Hodas, Mirabela Morariu, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 2 (2016): Issue 1 (March 2016)
Previous article
Next article